Cover image of the article: Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran

Image Credit:Inn J Pediatr

Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran

Authors

Shirin Farjadian1,*, Mozhgan Moghtaderi2, Sara Kashef3, Soheila Alyasin4, Khadijehsadat Najib5, Forough Saki6
*Corresponding Author: Email: farjadsh@sums.ac.ir

Innovative Journal of Pediatrics:Vol. 23, issue 2; 212-215
Published online:Jan 17, 2013
Article type:Brief Report
Received:Oct 23, 2012
Accepted:Dec 16, 2012
How to Cite:Farjadian S, Moghtaderi M, Kashef S, Alyasin S, Najib K, et al. Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran. Inn J Pediatr. 2013;23(2):. doi:

Abstract

Objective: Cystic fibrosis (CF) is a common autosomal recessive genetic disease caused by a mutation in the CF transmembrane conductance regulatory (CFTR) gene. This study attempted to identify the most common CFTR mutations and any correlations between certain mutations and the clinical presentation of the disease in CF patients in southwestern Iran.
Methods: Twenty nine common CFTR gene mutations were examined in 45 CF patients.
Findings: Chronic cough, intestinal obstruction, dehydration, heat exhaustion and steatorrhea were the most common early clinical symptoms among our patients. The most common mutation was ∆F508, with an allele frequency of 21%. The homozygous ∆F508 mutation was observed in eight patients (18%), and three patients (7%) were ∆F508 carriers. The 2183AA>G mutation was observed in four patients, one of whom was also a ∆F508 carrier. The R1162X mutation was detected in two patients. The G542X, R334W and N1303K mutations were detected each in one patient, the first of whom was also a ∆F508 carrier.
Conclusion: Out of 45 patients, 27 (60%) had none of the CFTR gene mutations we tested for. The most frequent mutations in southwestern Iranian patients with CF should be identified by sequencing the entire CFTR gene in order to optimize the design of a diagnostic kit for common regional mutations.

 

Highlights

References

  • 1.
    References are available on the PDF.

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

28
May
2014
Cystic fibrosis anddistribution and mutation analysis of CFTR gene in Iranian patients

Cystic fibrosis anddistribution and mutation analysis of CFTR gene in Iranian patients

Mohammad Reza Havasian,
Jafar Panahi,
Nejat Mahdieh

Havasian MR, Panahi J, Mahdieh N. Cystic fibrosis anddistribution and mutation analysis of CFTR gene in Iranian patients. koomesh. 2014;15(4):e152879. doi:

23
Dec
2015
Frequency of Genotype With ΔF508 Mutation in CFTR Gene Among Iranian Cystic Fibrosis Patients With Pancreatic Insufficiency

Frequency of Genotype With ΔF508 Mutation in CFTR Gene Among Iranian Cystic Fibrosis Patients With Pancreatic Insufficiency

Ahmad Khodadad,
Elaheh Elahi,
Setareh Sadat Bani Hassani,
Pejman Rouhani,
Bamdad Sadeghi,
Nima Rezaei

Khodadad A, Elahi E, Bani Hassani SS, Rouhani P, Sadeghi B, et al. Frequency of Genotype With ΔF508 Mutation in CFTR Gene Among Iranian Cystic Fibrosis Patients With Pancreatic Insufficiency. Inn J Pediatr. 2015;25(6):e3419. doi: https://doi.org/10.5812/ijp.3419

19
Mar
2017
The molecular analysis of mutations in exons 4, 11 and 21 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in cystic fibrosis patients in Kermanshah, Iran

The molecular analysis of mutations in exons 4, 11 and 21 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in cystic fibrosis patients in Kermanshah, Iran

Nasibe Karimi,
Ali Bidmeshkipour,
Keyghobad Ghadiri,
Reza Alibakhshi

Karimi N, Bidmeshkipour A, Ghadiri K, Alibakhshi R. The molecular analysis of mutations in exons 4, 11 and 21 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in cystic fibrosis patients in Kermanshah, Iran. J Kermanshah Univ Med Sci. 2017;20(4):e69663. doi: https://doi.org/10.22110/jkums.v20i4.2466

21
Feb
2015
Association of TNF-α Gene Variants With Clinical Manifestation of Cystic Fibrosis Patients of Iranian Azeri Turkish Ethnicity

Association of TNF-α Gene Variants With Clinical Manifestation of Cystic Fibrosis Patients of Iranian Azeri Turkish Ethnicity

Aziz Khorrami,
Mortaza Bonyadi,
Mandana Rafeey,
Omid Omrani

Khorrami A, Bonyadi M, Rafeey M, Omrani O. Association of TNF-α Gene Variants With Clinical Manifestation of Cystic Fibrosis Patients of Iranian Azeri Turkish Ethnicity. Inn J Pediatr. 2015;25(1):-. doi: https://doi.org/10.5812/ijp.307

1
Nov
2013
Clinical Scoring Systems in Cystic Fibrosis – What Are the Options for Developing Countries?

Clinical Scoring Systems in Cystic Fibrosis – What Are the Options for Developing Countries?

Brenda Morrow

Morrow B. Clinical Scoring Systems in Cystic Fibrosis – What Are the Options for Developing Countries?. J Compr Ped. 2013;4(4):e93768. doi: https://doi.org/10.17795/compreped-13158

More by these authors

Shirin FarjadianPubMedScholar
Mozhgan MoghtaderiPubMedScholar
Sara KashefPubMedScholar
Soheila AlyasinPubMedScholar
Khadijehsadat NajibPubMedScholar
Forough SakiPubMedScholar
Share
Cited by
Metrics